Guralnik Jack M, Ershler William B, Schrier Stanley L, Picozzi Vincent J
Virginia Mason Clinic, 1100 Ninth Avenue, Seattle, WA 98101-2799, USA.
Hematology Am Soc Hematol Educ Program. 2005:528-32. doi: 10.1182/asheducation-2005.1.528.
Over 3 million people in the United States aged 65 years and older are anemic. This condition is associated with significant functional impairment and, perhaps, increased mortality. In March 2004, the American Society of Hematology (in conjunction with the National Institute of Aging) convened a "blue ribbon" panel of twenty physicians who are experts on various aspects of this topic. This paper highlights important consensus concepts resulting from that meeting. In particular, four areas of thought are shared. First, the epidemiology of anemia in the elderly is reviewed, including its definition, its expression in different racial groups, and its wide-ranging manifestations. Second, the pathophysiology of anemia in the elderly is reviewed as pertains to three general etiological categories (nutritional, chronic diseases, and so-called "unexplained" anemias). Particular emphasis is given to pathophysiologic mechanisms of anemia that are potentially unique to this age group. Third, a practical approach to the diagnosis and management of anemia for this patient population for the practicing hematologist is provided. Finally, the public health implications of anemia in the elderly for key stakeholder constituencies will be discussed in the oral presentation.
在美国,超过300万65岁及以上的老年人患有贫血症。这种状况与严重的功能损害相关,甚至可能增加死亡率。2004年3月,美国血液学会(与美国国立衰老研究所联合)召集了一个由20位医生组成的“蓝带”小组,这些医生是该主题各个方面的专家。本文重点介绍了那次会议达成的重要共识观点。特别分享了四个思考领域。首先,回顾老年人贫血症的流行病学,包括其定义、在不同种族群体中的表现以及广泛的症状。其次,按照三个一般病因类别(营养性、慢性疾病以及所谓的“不明原因”贫血)回顾老年人贫血症的病理生理学。特别强调了可能是该年龄组独有的贫血症病理生理机制。第三,为执业血液学家提供了针对该患者群体贫血症诊断和管理的实用方法。最后,将在口头报告中讨论老年人贫血症对关键利益相关方群体的公共卫生影响。